By contrast, Gutie’rrez-Salmero’n et al. observed that the glucose-induced activation of AMPK plays alternative roles in normal and tumor tissues, suggesting that AMPK may shift from tumor suppressor to activator during tumor progression [39]. The gene discussed is PRKAA2; the disease is neoplasm.